See more
What is Genentech Patient Foundation?
The Genentech Patient Foundation gives free Genentech medicine to people who don't have insurance coverage or who have financial concerns and meet eligibility criteria.
What Is Genentech access Solutions?
Access Solutions is a program from Genentech and is committed to helping you understand your insurance coverage and options that might be able to help you pay for your Genentech medicine. Call (866) 422-2377 or visit Genentech-Access.com for more information.
What drugs does Genentech make?
Our Medicines & ProductsMedicines.Actemra® (TOCILIZUMAB [authorized for Emergency Use])Actemra® (tocilizumab)Activase® (alteplase)Alecensa® (alectinib)Avastin® (bevacizumab)Boniva Tablets® (ibandronate sodium)Cathflo Activase® (alteplase)More items...
What is Ophthalmology access solutions?
We focus on access so you can focus on health Genentech Ophthalmology Access Solutions is a program that helps people who are taking a Genentech medicine. Your health insurance plan and the cost of your medicine might keep you from getting your prescribed treatment.
Who makes Valganciclovir?
Genentech: Valcyte® (valganciclovir hydrochloride) - Information for Patients.
Does Pfizer own Genentech?
Roche Holding's agreement on Thursday to acquire full ownership of Genentech for $46.8 billion is the third big drug industry merger this year. But it is different from the other two — Pfizer's $68 billion proposal to acquire Wyeth and Merck's $41 billion deal with Schering-Plough — in crucial ways.
What is Genentech best known for?
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Where do Genentech employees live?
South San FranciscoWorking and living in South San Francisco, these employees are proud members of a thriving community.
How many drugs does Genentech have?
Genentech, Inc. manufactures, markets and/or distributes more than 47 drugs in the United States.
Which one of these is an approved drug by the firm Genentech?
The Genentech medicines supported by the Genentech Patient Foundation are: Actemra® (tocilizumab) Activase® (alteplase) Alecensa® (alectinib)
What drugs does Roche make?
All. Actemra/RoActemra. Alecensa. ... Anaemia. Mircera. NeoRecormon.Cancer (blood tumours) Gazyva/Gazyvaro. MabThera / Rituxan. ... Cancer (blood cancers) Alecensa. Avastin. ... Dermatology. Roaccutane/Accutane.Haemophilia. Hemlibra.Infectious Diseases. Actemra/RoActemra. Copegus. ... Inflammatory & Autoimmune Diseases. Actemra/RoActemra. CellCept.More items...
What MS drugs does Genentech make?
About OCREVUS OCREVUS is approved by the FDA to treat relapsing or primary progressive forms of multiple sclerosis (MS).
Apply For Help
If you are a health care provider, click below to learn how to apply online or via fax.
Health Care Providers
Health Care Providers can submit the completed Patient Consent and Prescriber Foundation form in two ways:
Patients
Step 1: Complete the online Patient Consent Form, which is available in English and Spanish: Patient Consent Form | Formulario de Consentimiento del Paciente
Who provides Genentech medicine?
The Genentech Patient Foundation provides free Genentech medicine to people who don't have insurance coverage or who have financial concerns and to people who meet certain income criteria.*
What is ACTEMRA Access Solutions?
For eligible patients with commercial or public health insurance, ACTEMRA Access Solutions offers referrals to independent co-pay assistance foundations.†
Does ACTEMRA have a copay card?
ACTEMRA Access Solutions can refer eligible patients to the ACTEMRA Co-pay Card Program for help with the out-of-pocket costs associated with their Genentech medicine.*
How to report side effects of Genentech?
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Genentech at 1-888-835-2555. Please see full Prescribing Information , including Boxed WARNINGS and Medication Guide, for additional Important Safety Information.
How long after stopping CellCept can you donate blood?
You should not donate blood while taking CellCept and for at least 6 weeks after stopping CellCept.
What are the infections that can happen with CellCept?
Viral infections that can happen with CellCept include: shingles, other herpes infections , and cytomegalovirus (CMV).
What is cellept used for?
CellCept. ®. (mycophenolate mofetil) is a prescription medicine to prevent rejection (antirejection medicine) in people who have received a kidney, heart or liver transplant. Rejection is when the body’s immune system perceives the new organ as a “foreign” threat and attacks it. CellCept is used with other medicines containing cyclosporine ...
How to report cellept side effects?
These are not all of the possible side effects of CellCept. Tell your doctor about any side effect that bothers you or that does not go away. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Genentech at 1-888-835-2555.
How to contact mycophenolateREMS?
by phone at 1-800-617-8191 or. by visiting the Risk Evaluation and Mitigation Strategy (REMS) website at www.mycophenolateREMS.com. The purpose of this registry is to gather information about the health of you and your baby. Increased risk of getting certain cancers.
Does cellcept cause side effects?
CELLCEPT CAN CAUSE SERIOUS SIDE EFFECTS, INCLUDING: Increased risk of loss of a pregnancy (miscarriage) and higher risk of birth defects. Females who take CellCept during pregnancy have a higher risk of miscarriage during the first 3 months (first trimester), and a higher risk that their baby will be born with birth defects.
Summary
Genentech, Inc. was founded in 1976 by Robert A. Swanson and Dr. Herbert W. Boyer. The company is primarily based around the field of recombinant DNA technology that was founded by Boyer and colleague Stanley Cohen. Over their 30+ year history, Genentech, Inc.
Eligibility
Genentech Access to Care Foundation (Pulmozyme), a patient assistance program provided by Genentech, Inc., offers Pulmozyme at no cost for one use to those who are eligible for the program. Eligibility is based off of the following requirements:
Other Tips
If you have any questions please call the Genentech, Inc. program directly.
Summary
Genentech, Inc. was founded in 1976 by Robert A. Swanson and Dr. Herbert W. Boyer. The company is primarily based around the field of recombinant DNA technology that was founded by Boyer and colleague Stanley Cohen. Over their 30+ year history, Genentech, Inc.
Eligibility
Genentech Access to Care Foundation (Rituxan RA), a patient assistance program provided by Genentech, Inc., offers Rituxan at no cost for up to 90 days to those who are eligible for the program. Eligibility is based off of the following requirements:
Other Tips
If you have any questions please call the Genentech, Inc. program directly.
